ZA946767B - Monocional antibodies having property of causing apoptosis. - Google Patents

Monocional antibodies having property of causing apoptosis.

Info

Publication number
ZA946767B
ZA946767B ZA946767A ZA946767A ZA946767B ZA 946767 B ZA946767 B ZA 946767B ZA 946767 A ZA946767 A ZA 946767A ZA 946767 A ZA946767 A ZA 946767A ZA 946767 B ZA946767 B ZA 946767B
Authority
ZA
South Africa
Prior art keywords
antibody
property
myelocytic
causing apoptosis
apoptosis
Prior art date
Application number
ZA946767A
Other languages
English (en)
Inventor
Naoshi Fukushima
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ZA946767B publication Critical patent/ZA946767B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA946767A 1993-09-03 1994-09-02 Monocional antibodies having property of causing apoptosis. ZA946767B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP05242110 1993-09-03

Publications (1)

Publication Number Publication Date
ZA946767B true ZA946767B (en) 1995-04-03

Family

ID=17084452

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946767A ZA946767B (en) 1993-09-03 1994-09-02 Monocional antibodies having property of causing apoptosis.

Country Status (19)

Country Link
US (4) US5840344A (de)
EP (1) EP0721015B1 (de)
KR (1) KR100241863B1 (de)
CN (1) CN1046314C (de)
AT (1) ATE280835T1 (de)
AU (1) AU692466B2 (de)
CA (1) CA2169950A1 (de)
CZ (1) CZ294359B6 (de)
DE (1) DE69434097T2 (de)
FI (1) FI960567A (de)
HU (1) HU222989B1 (de)
NO (1) NO960684D0 (de)
PL (1) PL181783B1 (de)
RU (1) RU2202615C2 (de)
SK (1) SK281964B6 (de)
TW (1) TW426687B (de)
UA (1) UA50708C2 (de)
WO (1) WO1995006748A1 (de)
ZA (1) ZA946767B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840344A (en) * 1993-09-03 1998-11-24 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibodies having property of causing apoptosis
AU2232597A (en) * 1996-03-06 1997-09-22 Chugai Seiyaku Kabushiki Kaisha Method of screening apoptosis inducing substances
DE69733204T3 (de) 1996-07-15 2012-03-08 Chugai Seiyaku K.K. Neuartige vegf-ähnliche faktoren
US7531643B2 (en) 1997-09-11 2009-05-12 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody inducing apoptosis
CN1198845C (zh) * 1997-09-11 2005-04-27 中外制药株式会社 诱导编程性细胞死亡的单克隆抗体
US7696325B2 (en) * 1999-03-10 2010-04-13 Chugai Seiyaku Kabushiki Kaisha Polypeptide inducing apoptosis
WO2000053634A1 (fr) * 1999-03-10 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Fv monocatenaire induisant l'apoptose
US20040058393A1 (en) * 2000-04-17 2004-03-25 Naoshi Fukishima Agonist antibodies
CN1308448C (zh) 2000-10-20 2007-04-04 中外制药株式会社 低分子化的tpo激动剂抗体
EP2351838A1 (de) * 2000-10-20 2011-08-03 Chugai Seiyaku Kabushiki Kaisha Vernetzende, agonistische Antikörper
US7195771B1 (en) 2000-11-21 2007-03-27 Kimberly-Clark Worldwide, Inc. Water-soluble lotions for paper products
WO2003044482A2 (en) * 2001-11-16 2003-05-30 The University Of Tennessee Research Corporation Recombinant antibody fusion proteins and methods for detection of apoptotic cells
EP1561759B9 (de) 2002-10-11 2009-08-26 Chugai Seiyaku Kabushiki Kaisha Zelltod-induzierender wirkstoff
JP2004279086A (ja) * 2003-03-13 2004-10-07 Konica Minolta Holdings Inc 放射線画像変換パネル及び放射線画像変換パネルの製造方法
EP1609803A4 (de) * 2003-03-31 2006-05-24 Chugai Pharmaceutical Co Ltd Modifizierter antikörper gegen cd22 und anwendungen dafür
TW200530269A (en) 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
TW200530266A (en) * 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Method of reinforcing antibody activity
EP1712565A4 (de) * 2003-12-12 2009-03-11 Chugai Pharmaceutical Co Ltd Den zelltod induzierende mittel
WO2005056602A1 (ja) * 2003-12-12 2005-06-23 Chugai Seiyaku Kabushiki Kaisha アゴニスト活性を有する改変抗体のスクリーニング方法
US9493569B2 (en) * 2005-03-31 2016-11-15 Chugai Seiyaku Kabushiki Kaisha Structural isomers of sc(Fv)2
WO2006123724A1 (ja) * 2005-05-18 2006-11-23 The University Of Tokushima 抗hla抗体を利用した新規医薬品
KR101360671B1 (ko) 2005-06-10 2014-02-07 추가이 세이야쿠 가부시키가이샤 ｓｃ（Ｆｖ）２를 함유하는 의약조성물
EP1908482B1 (de) 2005-06-10 2017-09-06 Chugai Seiyaku Kabushiki Kaisha Stabilisator für eine proteinzubereitung mit meglumin und seine verwendung
WO2007100892A2 (en) * 2006-02-28 2007-09-07 The Board Of Trustees Of The Leland Stanford Junior University Trojan horse immunotherapy
KR20090038896A (ko) * 2006-07-13 2009-04-21 추가이 세이야쿠 가부시키가이샤 세포사 유도제
CL2008000719A1 (es) * 2007-03-12 2008-09-05 Univ Tokushima Chugai Seiyaku Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
CN109072199B (zh) 2014-12-05 2022-10-28 纪念斯隆-凯特琳癌症中心 靶向Fc受体样5的嵌合抗原受体及其用途
CN109071654B (zh) 2015-12-04 2022-09-23 纪念斯隆-凯特琳癌症中心 靶向Fc受体样5的抗体及使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840344A (en) * 1993-09-03 1998-11-24 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibodies having property of causing apoptosis
AU2232597A (en) * 1996-03-06 1997-09-22 Chugai Seiyaku Kabushiki Kaisha Method of screening apoptosis inducing substances
CN1198845C (zh) * 1997-09-11 2005-04-27 中外制药株式会社 诱导编程性细胞死亡的单克隆抗体
WO2000053634A1 (fr) * 1999-03-10 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Fv monocatenaire induisant l'apoptose

Also Published As

Publication number Publication date
PL313260A1 (en) 1996-06-24
CN1046314C (zh) 1999-11-10
EP0721015B1 (de) 2004-10-27
HU222989B1 (hu) 2004-01-28
CN1130405A (zh) 1996-09-04
WO1995006748A1 (fr) 1995-03-09
EP0721015A1 (de) 1996-07-10
US20030147894A1 (en) 2003-08-07
DE69434097T2 (de) 2006-02-02
CZ294359B6 (cs) 2004-12-15
FI960567A0 (fi) 1996-02-07
HU9600206D0 (en) 1996-03-28
DE69434097D1 (de) 2004-12-02
FI960567A (fi) 1996-02-07
SK25596A3 (en) 1996-10-02
KR100241863B1 (ko) 2000-03-02
ATE280835T1 (de) 2004-11-15
UA50708C2 (uk) 2002-11-15
US5840344A (en) 1998-11-24
AU7546694A (en) 1995-03-22
HUT74594A (en) 1997-01-28
CA2169950A1 (en) 1995-03-09
CZ61796A3 (en) 1996-06-12
AU692466B2 (en) 1998-06-11
NO960684L (no) 1996-02-21
US6267959B1 (en) 2001-07-31
US6759043B2 (en) 2004-07-06
PL181783B1 (pl) 2001-09-28
NO960684D0 (no) 1996-02-21
SK281964B6 (sk) 2001-09-11
RU2202615C2 (ru) 2003-04-20
EP0721015A4 (de) 1999-03-31
US20010001712A1 (en) 2001-05-24
TW426687B (en) 2001-03-21

Similar Documents

Publication Publication Date Title
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
FI961285A0 (fi) CD40:n vasta-aineita
NO2006008I2 (no) Natalizumab, anti alfa-4 integrin humanized monoclonal antibody
DK0742795T3 (da) Immunstimulerende monoklonale antistoffer
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
NO973875L (no) Fremgangsmåte for stimulering av en immunrespons
AU1971295A (en) Humanized monoclonal antibodies against human interleukin-4
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
EP0287397A3 (en) Monoclonal antibody specific to human pancreatic phospholipase a2
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
AU1493995A (en) Monoclonal antibody
ITRM920223A0 (it) Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf.
DE69118702D1 (de) Neue verwendung eines monoklonalen antikörpers
ES2051870T3 (es) Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t.
AU6162794A (en) Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor
ATE58173T1 (de) Monoklonale antikoerper und immunisierung damit.